Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.735 USD | -1.96% | +3.76% | -2.63% |
05-02 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.63% | 1.35B | |
+32.03% | 50.85B | |
+0.87% | 42.82B | |
+48.88% | 42.03B | |
-4.22% | 29.55B | |
+10.95% | 26.11B | |
-22.09% | 19.13B | |
+8.06% | 13.05B | |
+26.62% | 12.16B | |
+23.33% | 12.08B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Needham Adjusts Price Target on Vir Biotechnology to $32 From $35, Maintains Buy Rating